Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates

International Journal of Antimicrobial Agents

Volumn 18, Issue 5, 2001, Pages 433-436

  Schmitz, Franz Josef ^a,b   Perdikouli, Mirella ^a   Beeck, Andreas ^a   Verhoef, Jan ^b   Fluit, A C ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Macrolide resistance; Penicillin resistance; Quinolone resistance; Resistance determinant; Streptococcus pneumoniae; Tetracycline resistance

Indexed keywords

BACTERIAL PROTEIN; CLINDAMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ERYTHROMYCIN; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; PROTEIN ERM; PROTEIN MEF; PROTEIN PARC; PROTEIN PARE; QUINOLONE; RIBOSOME PROTEIN; RIBOSOME PROTEIN L22; RIBOSOME PROTEIN L4; RNA 23S; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SURVEILLANCE PROGRAM; EUROPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; PENICILLIN RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; EUROPE; FLUOROQUINOLONES; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TETRACYCLINE RESISTANCE;

EID: 0035160751     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00427-7     Document Type: Article

References (17)

1. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae
2. Detection of erythromycin-resistant determinants by PCR
3. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America
4. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage
5. Prevalence of mefE, erm and tet(M) genes in Streptococcus pneumoniae strains from Central Italy
6. Identification of the tetracycline resistance gene, tet (O), in Streptococcus pneumoniae
7. Prevalence of gyrA, gyrB, parC and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different quinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season
8. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: Contributions of type II topoisomerase mutations and efflux to levels of resistance
9. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
10. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995
11. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France
12. Macrolide resistance in Belgian Streptococcus pneumoniae
13. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy
14. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates
15. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae
16. Macrolide resistance conferred by base substitutions in 23S rRNA